30Mar 2023
Comparing the Efficacy of Ultra Rapid Lispro versus Humalog in Reducing Postprandial Glucose in Type 1 Diabetes Patients of Different Age Groups

Comparing the Efficacy of Ultra Rapid Lispro versus Humalog in Reducing Postprandial Glucose in Type 1 Diabetes Patients of Different Age Groups

The study compared the pharmacokinetics, glucodynamics, and tolerability of ultra-rapid lispro (URLi) versus Humalog in children, adolescents, and adults with type 1 diabetes mellitus. The results showed that URLi had a faster onset of appearance, reduced early 50% tmax, and increased exposure in the first 15 minutes compared to Humalog, with similar maximum and overall exposure between treatments. URLi also demonstrated greater postprandial glucose reduction and was well tolerated in all age groups. Therefore, URLi may be a useful treatment option for individuals with type 1 diabetes mellitus.

  • #endo-diabetology

Like

Save

Share